How do we best measure the clinical benefit of a structure-modifying osteoarthritis drug?
Vignon EP, Moreland L. How do we best measure the clinical benefit of a structure-modifying osteoarthritis drug? Osteoarthritis Cartilage. 2004; 12 Suppl A:S61-2.